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Abstract
Aims
A very low calorie diet improves the metabolic regulation of obesity related type 2 diabetes,
but not for all patients, which leads to frustration in patients and professionals alike. The
aim of this study was to develop a prediction model of diet-induced weight loss in type 2
diabetes.
Methods
192 patients with type 2 diabetes and BMI>27 kg/m2 from the outpatient diabetes clinic of
the Erasmus Medical Center underwent an 8-week very low calorie diet. Baseline demo-
graphic, psychological and physiological parameters were measured and the C-index was
calculated of the model with the largest explained variance of relative weight loss using
backward linear regression analysis. The model was internally validated using bootstrap-
ping techniques.
Results
Weight loss after the diet was 7.8±4.6 kg (95%CI 7.2–8.5; p<0.001) and was independently
associated with the baseline variables fasting glucose (B = -0.33 (95%CI -0.49, -0.18), p =
0.001), anxiety (HADS; B = -0.22 (95%CI -0.34, -0.11), p = 0.001), numb feeling in extremi-
ties (B = 1.86 (95%CI 0.85, 2.87), p = 0.002), insulin dose (B = 0.01 (95%CI 0.00, 0.02), p =
0.014) and waist-to-hip ratio (B = 6.79 (95%CI 2.10, 11.78), p = 0.003). This model explained
25% of the variance in weight loss. The C-index of this model to predict successful (5%)
weight loss was 0.74 (95%CI 0.67–0.82), with a sensitivity of 0.93 (95% CI 0.89–0.97) and
specificity of 0.29 (95% CI 0.16–0.42). When only the obese T2D patients (BMI30 kg/m2;
n = 181) were considered, age also contributed to the model (B = 0.06 (95%CI 0.02, 0.11),
p = 0.008), whereas waist-to-hip ratio did not.
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Conclusions
Diet-induced weight loss in overweight adults with T2D was predicted by five baseline
parameters, which were predominantly diabetes related. However, failure seems difficult to
predict. We propose to test this prediction model in future prospective diet intervention stud-
ies in patients with type 2 diabetes.
Introduction
The metabolic regulation of obesity-related type 2 diabetes improves with diet-induced weight
loss. A very low calorie diet is successful in that respect, but unfortunately not in all patients,
which leads to feelings of failure and reduction of cost-effectiveness of the treatment. A predic-
tion model of weight loss can assist selecting those individuals that will benefit most.
The dramatic rise in the world-wide prevalence of obesity has led to a rising prevalence of
T2D. It is estimated that 82–87% of the T2D population are overweight or obese [1]. In patients
with T2D, a high BMI and waist circumference are associated with increased mortality [2,3].
Conversely, moderate weight loss improves glycaemic control, lipid profile and blood pressure
in these individuals and has been associated with reduced mortality [4–6]. Therefore, weight
loss is an important aspect of treatment of T2D. Weight loss of more than 5% results in impor-
tant health benefits and reduces health care costs [7,8]. However, not all individuals that are
overweight or obese achieve and maintain 5% weight loss or more with lifestyle interventions
[6,9]. Predictors of weight loss may be very helpful in optimizing individualized weight loss
strategies and in selecting those individuals who will benefit most from a diet, ultimately
improving treatment outcome and reducing health care costs. In adults with obesity, a number
of physiological and psychological predictors of weight loss have been identified. These include
sex, previous dieting for weight loss, initial weight, motivation, self-efficacy, self-esteem and
exercise [10,11]. However, these predictors of weight loss have not been studied in subjects
with T2D, and diabetes-specific variables have not been included in previous research in this
field. Both psychological and physiological factors are most probably of importance, as obesity-
related T2D is a complex multifactorial disease.
Therefore, the purpose of the present study was to identify which factors predict diet-
induced weight loss in overweight and obese adults with T2D, using psychological, physiologi-
cal as well as diabetes-related variables.
Materials and Methods
We enrolled participants of the run-in phase of the Prevention Of Weight Regain (POWER)
trial of which the protocol has been published previously [12]. This study was approved by the
Medical Ethics Committee of the Erasmus Medical Center in Rotterdam (reference number
MEC-2009-143/NL26508.078.09), in compliance with the Helsinki Declaration. All partici-
pants provided written informed consent before participating in this study.
Study population
Patients with T2D having BMI>27 kg/m2, whose age was 18–75 years, were recruited from the
outpatient diabetes clinic of the Erasmus Medical Center, Rotterdam from 2010–2013. Exclu-
sion criteria were pregnancy, lactation, severe psychiatric problems, significant cardiac arrhyth-
mias, unstable angina, decompensated congestive heart failure, major organ system failure,
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untreated hypothyroidism, and end-stage renal disease. Patients who had a myocardial infarc-
tion, cerebrovascular accident or major surgery during the previous 3 months were also
excluded.
Diet intervention and data collection
Intervention. After signing informed consent, participants followed a Very Low Calorie
Diet (VLCD) for a period of 8 weeks. The VLCD consisted of 2 commercially available meal
replacements per day (Glucerna SR1, Abbott Nutrition BV), plus 75 grams of lean meat, one
skimmed milk product and vegetables. Daily intake was approximately 750 kcal. Participants
received oral and written instructions on how to follow this diet at home. Before the start of the
diet the anti-diabetes medication was lowered to prevent hypoglycaemia: oral anti-diabetic
agents (except metformin) and short-acting insulin analogues were discontinued, while the
doses of long-acting insulin analogues and biphasic mixtures were halved. GLP-1 analogues
and DPP-4 inhibitors were continued. One week after starting the diet, participants received a
phone call of the research team. A structured discussion about blood glucose measurements,
questions about the diet, problems with adherence to the diet, and complaints was performed.
Participants were encouraged to follow the dietary recommendations of the study and to
weekly email their blood glucose measurements. The insulin dose was adjusted during the diet
period based on these daily glucose measurements.
Measures and outcomes. The primary outcome was weight loss, expressed as a percentage
of baseline bodyweight. At baseline and at the end of the diet intervention bodyweight was
measured. Weight loss was considered ‘successful’ if5% reduction of baseline body weight
was achieved. Moderate weight loss of5% is considered by the American Diabetes Associa-
tion and the European Association of the Study of Diabetes to produce significant health bene-
fits [13,14].
Besides age and sex, the baseline variables were as follows:
1. Weight and BMI
Weight was measured to the nearest 0.1 kg using the same Seca 888 compact digital flat
scale after removal of shoes. Height was measured to the nearest 0.5 cm without shoes using
a Seca stadiometer.
2. Waist circumference and waist-to-hip ratio
Waist circumference (cm) was measured at the level midway between the lowest rib margin
and the aliac crest. Hip circumference was measured at the widest point over the buttocks.
Both waist- and hip circumference were measured by the nearest 0,5 cm, using a tape-mea-
sure. Subsequently, waist-hip ratio (WHR) was calculated.
3. Glycemic control
a. Fasting glucose, measured using standard laboratory techniques
b. Hemoglobin A1c (HbA1c), measured using standard laboratory techniques
c. Total daily insulin dose (IU/day)
d. Total daily metformin dose (mg/day)
4. Physical complaints related to diabetes
a. Polyuria (yes/no)
b. Pruritus (yes/no)
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c. Eye problems (yes/no)
d. Numbness in extremities (yes/no)
5. Exercise
Days per week30 minutes of exercise
6. History of dieting for weight loss
Number of weight loss attempts
7. Fatigue
Measured by the Checklist Individual Strength (CIS) [15], which consists of 20 statements
for which the respondent has to indicate on a 7-point scale (from true to false) to what
extent the particular statement applies to him or her. The statements refer to four fatigue
aspects: (1) subjective fatigue (2) reduced motivation (3) reduced activity and (4) reduced
concentration. People with a score above 76 are at increased risk of long-term sickness
absence.
8. Depression and anxiety
Measured by the Hospital Anxiety and Depression scale (HADS). The HADS consists of a
7-item Anxiety scale and a 7-item Depression Scale. Each item is scored from 0 to 3. A total
score on either scale below 8 excludes anxiety or depression, respectively. A score of 8–10
and 11–21 indicates a possible and probable anxiety/depression, respectively [16].
9. Quality of life
Measured by the EQ-5D VAS score, ranging from 0 (death) to 100 (perfect health) [17,18]
10. Self-esteem
Measured by the Rosenberg Self-esteem Scale (RSE), which is a 10-item questionnaire that
measures global self-esteem. Items are scored on a 4-point scale. A higher score indicates a
more positive self-esteem. Scores below 21 indicate low self-esteem [19]
11. Eating disorders
a. Measured by the Eating Disorder Examination-Questionnaire (EDE-Q), a 36 item ques-
tionnaire that measures concerns about shape, weight and eating, restraint and binge eat-
ing. Total EDE-Q score range between 0–6. A higher score indicates more severe eating
psychopathology [20].
b. Binge eating disorder (BED), measured by use of the DSM-V criteria (yes/no)
All data were filed in a database using a trial management system (OpenClinica1).
Statistical Analysis
Variables at baseline were expressed as number with percentage or mean with standard devia-
tion. Prior to analysis, missing data were imputed using regression imputation. Participants
with more than 50% missing data were excluded. For 7 participants, whose body weight at the
end of the diet intervention was not available due to attrition, we assumed 0% weight loss. We
analysed the data according to the intention-to-treat as well as the per-protocol principle,
leaving those 7 patients out of the analysis. The average weight loss was analysed using a
paired samples t-test. The difference between groups at baseline was tested with a Chi-Square
test, an independent samples t-test or a Mann-Whitney U test, depending on normality of the
data. Potential predictors were identified by univariate regression analyses with percentage
weight loss as dependent variable. Subsequently, all variables were entered into a multiple
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regression analysis. The least informative covariates were successively removed from the
model in a backward stepwise elimination procedure based on the Akaike information crite-
rion (AIC)[21]. We accepted a maximum Variance Inflation Factor of 5 to exclude multicolli-
nearity problems. Each step of the backward regression analysis was internally validated using
bootstrapping [22]. In short, 1000 bootstrap cohorts (of equal size as the original dataset)
were randomly drawn, with replacement, from the cases in the original dataset. Logistic
regression was applied to predict successful ( 5% = 1) and unsuccessful (< 5% = 0) weight
loss. The relationship between false positives (1—specificity) and true positives (sensitivity) of
this prediction was presented in a ROC (Receiving Operating Characteristic) curve. For the
dichotomized prediction, the sensitivity, specificity and positive predictive value were calcu-
lated. Statistical significance was set at p< 0.05. All data processing and analyses were carried
out in SPSS (version 21).
Results
FromMarch 2010 to May 2013, we assessed 296 patients with BMI>27 kg/m2 and T2D from
our out-patient diabetes clinic, of whom 276 were eligible and 206 were willing to participate in
this study (Fig 1). Individuals who declined to participate were older (58.0 (49.8–64.0) years vs.
53.5 (47.0–61.8) years, p = 0.04) and more often male (61% vs. 42%, p = 0.005) than the indi-
viduals who were willing to participate in this study. Ethnicity did not differ. The main reasons
for the declined participation were work related and lack of time. Fourteen participants did not
fill out the questionnaires and did not provide blood samples, hence we collected data from
192 participants.
Table 1 shows baseline characteristics of our study population, of which 58% were female.
Of the participants, 181 (94.3%) had a BMI>30 kg/m2, thus qualified as obese. Mean HbA1c
and fasting glucose levels were well above target levels despite antidiabetic medication. Sixty-
two percent of the participants used insulin (62.0±63.9 IU/day). According to the HADS norm,
18% had a clinical depression and 20% a clinical anxiety disorder. Twelve participants (6.3%)
used antidepressants (self-reported).
After 8 weeks of VLCD, participants had lost 7.8±4.6 kg (95%CI 7.2–8.5; p<0.001). Twenty-
five percent of the participants lost less than 5%, 28% lost 5–7.5%, 21% lost 7.5–10% and 26%
lost more than 10% of their bodyweight. Compared with the successful weight loss group, the
unsuccessful weight loss group (i.e.<5%) showed higher levels of HbA1c and fasting glucose,
and were more likely to have pruritus and a lower self-esteem (p<0.01).
In univariate regression analyses (Table 2), age, waist-to-hip ratio, numb feeling in extremi-
ties, and self-esteem were all positively associated with relative weight loss, while female sex,
fasting glucose, HbA1c, pruritus and anxiety were negatively associated with relative weight
loss.
Table 3 shows the results of the multiple linear regression analysis. Since both fasting glu-
cose and HbA1c, and waist circumference and waist-to-hip ratio were strongly correlated
(p<0.001), we included only fasting glucose and waist-to-hip ratio in the multivariate analysis
to avoid multicollinearity problems. In the backward stepwise elimination multiple regression
analysis (using bootstrapping), the final model contained 5 baseline variables which were inde-
pendently associated with relative weight loss: the higher the reported numb feeling in extremi-
ties (B = 1.86 (95%CI 0.85, 2.87), p = 0.002), insulin dose (B = 0.01 (95%CI 0.00, 0.02), p =
0.014) and waist-to-hip ratio (B = 6.79 (95%CI 2.10, 11.78), p = 0.003), and the lower the fast-
ing glucose level (B = -0.33 (95%CI -0.49, -0.18), p = 0.001) and anxiety score (HADS; B =
-0.22 (95%CI -0.34, -0.11), p = 0.001), the greater the relative weight loss. These five parameters
together explained 25% of the variance of relative weight loss (R2 = 0.25, F(5) = 12.54,
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p<0.001). In Fig 2, we show the ROC curve of our intention-to-treat model in discriminating
unsuccessful (<5%) from successful (5%) weight loss, which had a C-index of 0.74 (95%CI
0.67–0.82). The logistic model had 0.80 (95% CI 0.74–0.86) post-test likelihood of predicting
successful weight loss and 0.58 (95% CI 0.39–0.78) post-test likelihood of predicting unsuccess-
ful weight loss. The model yielded 134 true positive, 34 false positive, 10 false negative and 14
true negative predictions. Hence, the sensitivity of this model was 0.93 (95% CI 0.89–0.97) and
the specificity was 0.29 (95% CI 0.16–0.42). When we corrected this model for change in insu-
lin dose during the diet, the five baseline variables remained significantly associated with rela-
tive weight loss; the model now explained 30% of the variance of weight loss (R2 = 0.30, F(6) =
13.31, p<0.001) and discriminated successful from unsuccessful weight loss with a C-index of
0.75. However, the VIF statistics for insulin dose and insulin change was 7, indicating possible
multicollinearity problems.
We conducted the multivariate regression analysis in a backward stepwise manner, to
obtain the optimal model. Alternatively, putting all the univariately associated variables
Fig 1. Study flow chart.
doi:10.1371/journal.pone.0160774.g001
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(p<0.1) in the multivariate regression model only marginally affected the performance of the
model (R2 = 0.29, F(11) = 6.53, p<0.001; C-index = 0.77).
When we excluded the 7 participants who did not finish the diet intervention (per protocol
analysis), the model slightly improved, as indicated by the additional contribution of the vari-
ables pruritus and quality of life (EQ5D VAS). The lower the reported pruritus and the higher
the perceived quality of life, the greater was the weight loss. This model explained 30% of the
variance of relative weight loss (R2 = 0.30, F(8) = 9.29, p<0.001) and discriminated successful
from unsuccessful weight loss with a C-index of 0.79.
We also performed the analysis for the obese subgroup (BMI30 kg/m2; n = 181) only.
Compared to the entire study population, age now also contributed to the model (B = 0.06
(95%CI 0.02, 0.11), p = 0.008), whereas waist-to-hip ratio was removed from the model in the
backward elimination procedure. The model containing fasting glucose, insulin dose, age,
numb feeling in extremities and anxiety score explained 25% of the variance of relative weight
loss (R2 = 0.25, F(5) = 11.84, p<0.001), and discriminated successful from unsuccessful weight
loss with a C-index of 0.73.
Table 1. General baseline characteristics (n = 192).
Characteristics Value, mean ± SD (range)
Age (y) 54.2 ± 10.6 (26–75)
Sex, female (n (%)) 112 (58%)
Exercise (weekly days 30 min. exercise) 5.3 ± 2.3 (0–7)
Physiological variables:
Weight (kg) 106.0 ± 19.0 (69.4–169.2)
BMI (kg/m2) 37.0 ± 5.6 (27.3–62.6)
Waist circumference (cm) 120.2 ± 13.3 (90–163)
Waist-to-hip ratio 1.0 ± 0.1 (0.8–1.3)
HbA1c (mmol/mol) 63.9 ± 15.2 (32–126)
HbA1c (%) 8.0 ± 1.4 (5.1–13.7)
Fasting glucose (mmol/l) 9.5 ± 3.2 (3.2–21.1)
Insulin dose (IU)a and users (n (%)) 100.1 ± 52.7 (8–248) 119 (62%)
Metformin dose (mg)a and users (n (%)) 1774.8 ±754.2 (500–3000) and users (n (%))
Numb feeling in extremities (n (%)) 96 (50%)
Polyuria (n (%)) 57 (30%)
Pruritus (n (%)) 37 (19%)
Diabetes-related eye problems (n (%)) 45 (23%)
Psychological variables:
Depression score (HADS 0–20) 7.0 ± 4.0 (0–20)
Clinical depression (n (%)) 35 (18%)
Anxiety score (HADS 0–20) 6.6 ± 4.3 (0–20)
Clinical anxiety disorder (n (%)) 38 (20%)
Self-esteem (RSE 0–40) 30.6 ± 5.6 (13–40)
Quality of life (EQ5D VAS 1–100) 58.8 ± 21.0 (10–100)
Fatigue (CIS total score 20–140) 80.9 ± 23.8 (25–133)
Eating disorders (EDE-Q total score 0–6) 2.2 ± 1.2 (0–5.4)
Binge eating disorder (DSM V, n (%)) 11 (6%)
Diet history (no. of weight loss attempts) 1.0 ± 1.1 (0–5)
adose only in users
doi:10.1371/journal.pone.0160774.t001
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Discussion
In this pragmatic explorative study, we found that successful diet-induced weight loss can be
predicted in overweight adults with T2D by the baseline variables fasting glucose, anxiety,
numb feeling in extremities, insulin dose and waist-to-hip ratio. However, failure seems more
difficult to predict. Surprisingly, the ‘usual suspects’ in predicting weight loss in individuals
Table 2. Univariate linear regression analysis of relative weight loss with baseline variables.
Covariate B SE β p
Age (y) 0.086 0.026 0.237 0.001
Sex (female) -1.908 0.547 -0.246 0.001
Exercise (weekly days 30 min. exercise) 0.137 0.119 0.083 0.251
Physiological variables:
Weight (kg) 0.014 0.015 0.071 0.325
Waist circumference (cm) 0.040 0.021 0.137 0.058
Waist-to-hip ratio 10.160 2.927 0.244 0.001
Fasting glucose (mmol/l) -0.311 0.085 -0.257 <0.001
HbA1c (mmol/mol) -0.046 0.018 -0.181 0.012
Insulin dose (IU) 0.008 0.004 0.131 0.070
Insulin dose change during diet (IU) -0.019 0.006 -0.245 0.001
Metformin dose (mg) <0.0001 <0.0001 0.007 0.922
Numbness in extremities (n = 0/y = 1) 1.792 0.540 0.234 0.001
Polyuria (n = 0/y = 1) 0.019 0.608 0.002 0.976
Pruritus (n = 0/y = 1) -1.732 0.693 -0.178 0.013
Diabetes-related eye problems (n = 0/y = 1) -0.648 0.654 -0.072 0.324
Psychological variables:
Depression score (HADS 0–20) -0.132 0.070 -0.136 0.060
Anxiety score (HADS 0–20) -0.223 0.062 -0.252 <0.001
Self-esteem (RSE 0–40) 0.126 0.049 0.184 0.011
Quality of life (EQ5D VAS 1–100) 0.024 0.013 0.131 0.071
Fatigue (CIS total score 20–140) -0.011 0.012 -0.065 0.371
Eating disorders (EDE-Q total score 0–6) -0.276 0.238 -0.084 0.247
Binge eating disorder (DSM V, n = 0/y = 1) 0.049 1.189 0.003 0.967
Diet history (no. of weight loss attempts) -0.111 0.248 -0.032 0.656
doi:10.1371/journal.pone.0160774.t002
Table 3. Multiple linear regression model (backward stepwise elimination using bootstrapping) of relative weight loss with baseline variables.
Variable B 95%CI 95%CI R2 p
Lower Upper
Fasting glucose (mmol/l) -0.332 -0.485 -0.180 0.078 0.001
Insulin dose (IU) 0.010 0.002 0.018 0.032 0.014
Waist-to-hip ratio 6.790 2.096 11.775 0.025 0.003
Numbness in extremities 1.860 0.853 2.874 0.065 0.002
Anxiety (HADS) -0.219 -0.344 -0.111 0.056 0.001
Explained variance in this model R2 = 0.25, F(5) = 12.54, p<0.001; C-index = 0.74. Variables entered into the model: age; sex; weight; waist-to-hip ratio;
fasting glucose; total daily insulin dose; total daily metformin dose; physical complaints related to diabetes (polyuria, pruritus, eye problems, numbness in
extremities, all yes/no); exercise (days per week30 minutes of exercise); history of weight loss dieting (number of different diets); fatigue (Checklist
Individual Strength); depression and anxiety (Hospital Anxiety and Depression scale); quality of life (EQ-5D VAS score); self-esteem (Rosenberg self-
esteem); eating disorders (EDE-Q); and binge eating disorder (DSM-V criteria, yes/no).
doi:10.1371/journal.pone.0160774.t003
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with obesity but without T2D, such as initial weight, diet history, self-esteem and exercise, did
not contribute to the model. Remarkably, 3 out of 5 predictors in the model were related to dia-
betes. This suggests that diabetes control is of major importance for overweight and obese
patients with T2D, who aim at losing weight, more than factors that are most relevant in non-
diabetic persons with obesity.
Our data showed that participants with a higher baseline fasting glucose and, hence, worse
diabetes control were less successful in achieving weight reduction. One could speculate that
controlling diabetes might require skills that are also important in controlling weight. A recent
review by Ahola, et al. found that factors associated with good management of diabetes
included individual issues such as self-efficacy, motivation, coping and problem-solving skills,
as well as issues related to the environment such as social support and socio-economic factors
[23]. All of these factors have been linked with successful weight loss as well [10]. Alternatively,
participants with a high fasting glucose may lose energy through glycosuria. Losing weight
reduces blood glucose levels in T2D [6] and subsequently the energy deficit due to glycosuria
may disappear, leading to a disadvantage in weight loss for participants with a very high fasting
glucose at baseline.
Fig 2. ROCCurve of multiple logistic regression model of successful relative weight loss (5%).
Variables included in the multiple linear regression model: fasting glucose level, insulin dose, waist-to-hip
ratio, numb feeling in extremities and anxiety score.
doi:10.1371/journal.pone.0160774.g002
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We identified anxiety as an unexpected negative predictor for weight loss. Among our par-
ticipants with T2D, the prevalence of anxiety disorder was as high as 20%. This is higher than
the prevalence of anxiety disorder in the Dutch population (7.7% for males and 12.5% for
females [24]), and in line with previous studies in T2D [25]. While anxiety has not been exten-
sively studied in the context of weight control, it has been correlated with a defensive coping
style: avoiding problems rather than solving them [26]. In diabetes, an anxious, defensive cop-
ing style has been associated with decreased adherence to therapy [27]. Similarly, in our study
anxiety could have led to a decreased adherence to the diet. A more autonomous coping strat-
egy has been shown to correlate better with the capability to lose weight than a defensive cop-
ing style [11,28]. It would be interesting to test whether treating anxiety prior to the diet
intervention would improve the success rate of a weight loss diet.
Baseline insulin dose was positively associated with weight loss. Before starting with the
VLCD, we reduced the insulin dose by more than 50% to avoid hypoglycaemic events. Insulin
use has been associated with weight gain due to the stimulation of lipogenesis and a reduction
of lipolysis and glycosuria [29]. Lowering the insulin dose could have had the opposite effect,
where participants on a high baseline dose could have had more benefit from the greater abso-
lute reduction of insulin dose. Reducing the insulin dose before a weight loss attempt is impor-
tant to prevent hypoglycaemia, but it may also enhance weight loss. Indeed, baseline insulin
dose and change in insulin dose were highly correlated (r = -0.929, p<0.001), so the association
of baseline insulin with weight loss could very well have been the effect of lowering the insulin
dose. However, when we corrected the model for change in insulin dose, baseline insulin dose
was still significantly associated with relative weight loss.
Experiencing a numb feeling in extremities was positively associated with the relative weight
loss. Of the participants who lost less than 5% weight, 35% reported this complaint, compared
with 55% in the successful weight loss group. A numb feeling in extremities could be associated
with diabetic neuropathy. Indeed, numbness was significantly correlated with a history of dia-
betic neuropathy (data not shown) and therefore probably with the severity of complications.
Complications or perceiving more complaints could be a motivational trigger for patients to
adhere to the diet regimen, although this has not been studied previously.
Participants with a higher waist-to-hip ratio and to a lesser extent waist circumference, i.e.
more abdominal fat, were more prone to lose weight in our study population. Moderate weight
loss, particularly by a VLCD, has been shown to result in preferential loss of visceral fat mass
[30]. Visceral fat mass is associated with reduced insulin sensitivity and increased systemic
low-grade inflammation [2,31]. Men tend to have a higher waist-to-hip ratio than women, as
was the case in our population (1.07±0.07 vs. 0.94±0.06, p<0.001). Since males have a higher
energy expenditure compared to women, and the diet intervention was the same for both men
and women, the association we found could be explained by the higher energy deficit for the
male participants. Accordingly, the univariate analysis showed that women lost significantly
less weight than men, suggesting that men will benefit most from weight reduction and prefer-
ential abdominal fat mass loss. However, in the multiple linear regression analysis, sex no lon-
ger contributed significantly to weight loss while waist-to-hip ratio remained an independent
contributor. Waist-to-hip ratio is a stronger predictor for weight loss success than sex.
A number of covariates, such as baseline bodyweight, self-motivation, diet history and self-
esteem have previously been associated with diet-induced weight loss in individuals with obe-
sity [10,11]. However, they did not predict relative weight loss in the present study. Self-esteem
was positively associated with weight loss in the univariate analysis, but no longer in the multi-
ple analysis. In concordance with most other studies on predictors of weight loss in subjects
with obesity [10,32], binge eating disorders and baseline exercise behaviour were not associated
with weight loss. In previous studies, depression or other measures of psychological well-being
Predictors of Weight Loss in Type 2 Diabetes
PLOS ONE | DOI:10.1371/journal.pone.0160774 August 5, 2016 10 / 13
were not predictive for weight loss [33], as was the case in the present study, or were negatively
associated with weight loss [34].
Limitations and Strengths
The present study is a pragmatic and explorative before-after study in the run-in phase of a
trial. We internally validated our results using statistical techniques (bootstrapping), however,
future prospective replication studies are required in order to confirm our findings. With the
baseline variables that were included in our study, 25% of the variance of weight loss could be
explained, leaving a large part unexplained. Future studies could build further on the model
presented here in an independent patient cohort, including other possible predictors like
plasma hormone levels or genomic profiles. A limitation of this study is the relatively low num-
ber of participants with unsuccessful weight loss, diminishing the discriminating power of the
model. Due to the academic hospital setting, our study population may not be representative of
the general population with T2D and overweight. However, a substantial percentage of our
population had been referred to us by the general practitioner with participation in our study
as exclusive purpose, leading to a relatively heterogeneous patient cohort in a ‘real life’ clinical
setting. Finally, we studied the short-term effect of the diet intervention only. However, a rela-
tively quick success of the intervention in terms of weight loss and improved glycemic control
may motivate the patients with obesity and diabetes to change lifestyle necessary to achieve
long term health benefit. Additional studies are required to determine whether the model also
predicts long-term maintenance of weight loss. Strengths of the current study are the prospec-
tive design, the relative large cohort of patients with T2D, the low attrition rate (3%) and the
consideration of psychological as well as physiological variables.
Conclusion and clinical implications
The current study suggests that diet-induced weight loss can be predicted by five easily measur-
able psychological and physiological variables, with a positive post-test probability of 80%. Dia-
betes specific variables were better at predicting successful weight loss during a VLCD than the
predictors known from non-T2D obese cohorts. Future prospective studies in the T2D popula-
tion are needed in order to replicate these findings. Restricting a VLCD to individuals with a
high post-test likelihood of successful weight loss seems attractive as it might increase efficacy
and improve the cost-effectiveness. Such screening of patients and predicting their treatment
success will bring us one step closer to personalized treatment of diabetes.
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